Talk title
"Open drug discovery: From genes to affordable medicines"

Aled is the current and founding CEO of the Structural Genomics Consortium (SGC), a charity aiming to place information and reagents about human proteins into the public domain without restriction.  The SGC focuses on under-studied proteins, including those that linked to human disease, including ALS/MND.  Aled shall be speaking about this effort.